WGS
GeneDx Holdings Corp.
Nasdaq Services-Health Services Large accelerated filer

Key Financials

Operating Income
$-13077000
↑ 43.7%
Gross Profit
$298.2M
↑ 53.4%
Net Income
$-21021000
↑ 59.8%
Revenue
$427.5M
↑ 40.0%
EPS (Diluted)
$-0.73
↑ 62.4%
Total Liabilities
$215.5M
↑ 23.8%
Shareholders' Equity
$308.2M
↑ 25.7%
Long-term Debt
$54.5M
↓ 2.2%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G 8/11/2026 View on SEC
SCHEDULE 13G/A 8/7/2026 View on SEC
10-Q 8/3/2026 View on SEC
8-K 8/3/2026 View on SEC
SCHEDULE 13G 7/28/2026 View on SEC
25-NSE 7/21/2026 View on SEC
4 7/1/2026 View on SEC
4 6/23/2026 View on SEC
4 6/23/2026 View on SEC
4 6/23/2026 View on SEC

Company Information

Field Value
Ticker WGS
Company Name GeneDx Holdings Corp.
CIK 1818331
Sector Services-Health Services
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 8000
SIC Description Services-Health Services
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone 888-729-1206